Analysis of the global burden of disease study highlights the global, regional, and national trends of idiopathic epilepsy epidemiology from 1990 to 2019

• Published in: Preventive medicine reports Vol. 36; p. 102522
• Main Authors: Zhang, Yuan-Jie, Kong, Xiang-Meng, Lv, Jia-Jie, Yang, Cheng-Hao, Li, Xin-Yu, Yang, Xi-Tao, Guo, Zhi-Lin, Cheng, Zhi-Hua
• Format: Journal Article
• Language: English
• Published: United States Elsevier 01.12.2023
• Subjects: Disability-adjusted life years; Epilepsy; Global Burden of disease; Incidence; Prevalence; Regular article; Global Burden of disease; Prevalence; Disability-adjusted life years; Epilepsy; Incidence
• ISSN: 2211-3355; 2211-3355
• DOI: 10.1016/j.pmedr.2023.102522

Epilepsy is a profound disorder, accounting for roughly 1% of the global disease burden. It can result in premature death and significant disability. To comprehensively understand the current dynamics and trends of idiopathic epilepsy, a deep insight into its epidemiological attributes is vital. We evaluated the incidence, prevalence, mortality, and disability-adjusted life years associated with idiopathic epilepsy from 1990 to 2019 using data and methodologies from the Global Burden of Disease Study. In 2019, there were approximately 2,898,222 individuals diagnosed with idiopathic epilepsy. Intriguingly, from 1990 to 2019, the age-standardized incidence rate of idiopathic epilepsy was consistently lower in women compared to men. Over these three decades, global mortality connected to idiopathic epilepsy increased by 13.95%. However, within the same period, age-standardized death rates for idiopathic epilepsy decreased from 1.94 per 100,000 population to 1.46 per 100,000 population. Predictions indicate an increase in the incidence of idiopathic epilepsy across all age brackets through 2035, especially among the elderly aged 80 and above. Mortality rates are projected to climb for those aged 80 and above while remaining relatively unchanged in other age demographics. Idiopathic epilepsy continues to be a significant contributor to both disability and death. The findings of our study underscore the critical importance of incorporating idiopathic epilepsy management into modern healthcare frameworks. Such strategic inclusion can enhance public awareness of relevant risk factors and the range of available therapeutic interventions.